IL42787A - Compositions for promotion of protein synthesis and suppression of urea formation in the body utilizing alpha-hydroxy acid analogs of amino acids - Google Patents

Compositions for promotion of protein synthesis and suppression of urea formation in the body utilizing alpha-hydroxy acid analogs of amino acids

Info

Publication number
IL42787A
IL42787A IL42787A IL4278773A IL42787A IL 42787 A IL42787 A IL 42787A IL 42787 A IL42787 A IL 42787A IL 4278773 A IL4278773 A IL 4278773A IL 42787 A IL42787 A IL 42787A
Authority
IL
Israel
Prior art keywords
parts
sodium
composition
hydroxy
calcium salt
Prior art date
Application number
IL42787A
Other languages
English (en)
Other versions
IL42787A0 (en
Original Assignee
Mac Kenzie Walser
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mac Kenzie Walser filed Critical Mac Kenzie Walser
Publication of IL42787A0 publication Critical patent/IL42787A0/xx
Publication of IL42787A publication Critical patent/IL42787A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL42787A 1973-04-30 1973-07-19 Compositions for promotion of protein synthesis and suppression of urea formation in the body utilizing alpha-hydroxy acid analogs of amino acids IL42787A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35532673A 1973-04-30 1973-04-30

Publications (2)

Publication Number Publication Date
IL42787A0 IL42787A0 (en) 1973-10-25
IL42787A true IL42787A (en) 1977-05-31

Family

ID=23397057

Family Applications (1)

Application Number Title Priority Date Filing Date
IL42787A IL42787A (en) 1973-04-30 1973-07-19 Compositions for promotion of protein synthesis and suppression of urea formation in the body utilizing alpha-hydroxy acid analogs of amino acids

Country Status (7)

Country Link
JP (1) JPS49135966A (fr)
BE (1) BE803567A (fr)
CA (1) CA1023664A (fr)
DE (1) DE2335216A1 (fr)
FR (1) FR2226994B1 (fr)
GB (1) GB1442154A (fr)
IL (1) IL42787A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950529A (en) * 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same
DE2530246A1 (de) * 1975-07-07 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung
DE2531299A1 (de) * 1975-07-12 1977-01-13 Fresenius Chem Pharm Ind L-amino- und hydroxy- und/oder ketosaeuren enthaltende gemische fuer parenterale oder orale anwendung
DE2636828A1 (de) * 1976-08-16 1978-02-23 Fresenius Chem Pharm Ind L-amonosaeurengemische fuer die behandlung von leberinsuffizienz sowie die herstellung derartiger gemische
US4296127A (en) * 1979-04-18 1981-10-20 The Johns Hopkins University Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof
US4752619A (en) * 1985-12-23 1988-06-21 The Johns Hopkins University Nutritional supplement for treatment of uremia
SE8803143L (sv) * 1988-09-07 1990-03-08 Kabivitrum Ab Alternativa energisubstrat
DE3943424A1 (de) * 1989-12-30 1991-07-04 Nephro Medica Pharma Infusions- und injektionsloesung zur intravenoesen verabreichung
US20140037604A1 (en) * 2011-04-18 2014-02-06 Nestec S.A. Nutritional compositions comprising alpha-hydroxyisocaproic acid

Also Published As

Publication number Publication date
FR2226994B1 (fr) 1977-08-12
FR2226994A1 (fr) 1974-11-22
BE803567A (fr) 1973-12-03
CA1023664A (fr) 1978-01-03
AU6015373A (en) 1975-03-13
IL42787A0 (en) 1973-10-25
DE2335216A1 (de) 1974-11-21
GB1442154A (en) 1976-07-07
JPS49135966A (fr) 1974-12-27

Similar Documents

Publication Publication Date Title
US4100161A (en) Promotion of protein synthesis and suppression of urea formation in the body by keto analogs of essential amino acids
US4826875A (en) Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
US4100160A (en) Therapeutic compositions comprising alpha-hydroxy analogs of essential amino acids and their administration to humans for promotion of protein synthesis and suppression of urea formation
CA2341601C (fr) Utilisation du selenium pour le traitement de patients atteints d'un syndrome de reponse inflammatoire systemique (sirs), et composition pour la mise en oeuvre du traitement
US5863906A (en) Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man
KR840003414A (ko) 3-히드록시부탄산 또는 이 산으로부터 유도된 염을 함유하는 약학적 조성물과, 의약품으로 사용할 수 있는 3-히드록시부탄산으로부터 유도된 화합물
JPH09512552A (ja) 腎疾患および不全の治療方法ならびに組成物
AU627041B2 (en) Improved nutritional formulation for the treatment of renal disease
IL42787A (en) Compositions for promotion of protein synthesis and suppression of urea formation in the body utilizing alpha-hydroxy acid analogs of amino acids
EP1062879B1 (fr) Solution aqueuse pour nutrition parentérale
OKITA et al. Nutritional treatment of liver cirrhosis by branched-chain amino acid-enriched nutrient mixture
IL42726A (en) Composition for promotion of protein synthesis and suppression of urea formation in the body
Connors et al. The pharmacology and tumour growth inhibitory activity of 1-aminocyclopentane-1-carboxylic acid and related compounds
AU690533B2 (en) Protein preparation for the prevention and therapy of periodontitis or other bacterial pathologies of the oral cavity
FI88581B (fi) Foerfarande foer framstaellning av en naeringstillsats foer behandling av uremi
Gershoff et al. Effect of vitamin B6 and magnesium on renal deposition of calcium oxalate induced by ethylene glycol administration.
MX2022015524A (es) Formas cristalinas del acido {2-[3-ciclohexil-3-(trans-4-propoxi-c iclohexil)-ureido]-tiazol-5-ilsulfanil}-acetico y uso de las mismas.
EP1419129A4 (fr) Utilisation d'acides gras a chaine ramifiee et derives de ces acides gras pour le traitement de la douleur
KR20070086007A (ko) 당뇨병의 치료를 위한 의약 조성물
JPH04312527A (ja) 肝不全および肝臓疾患の治療方法
GB1575646A (en) Therapeutic compositions and their administration
KR920006904B1 (ko) 디메르캅토 숙신산(dmsa)을 활성성분으로 한 약제학적 조성물
US20070141121A1 (en) Method of treating kidney disease
US20080102042A1 (en) Oral Composition
JPH02131421A (ja) 肝障害抑制剤